Vivek Ramaswamy (Jeff Rumans/JPM 2020)
Vivek Ramaswamy eyes an I/O vant with up to $2B licensing deal
Has Vivek Ramaswamy found the seed of his next vant?
On Monday, Roivant announced a rare partnership deal, signing an agreement with the German immuno …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
